A citation-based method for searching scientific literature

Ingo Vernaleken, Hans-Georg Buchholz, Yoshitaka Kumakura, Thomas Siessmeier, Peter Stoeter, Peter Bartenstein, Paul Cumming, Gerhard Gründer. Hum Brain Mapp 2007
Times Cited: 50







List of co-cited articles
479 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Andreas Meyer-Lindenberg, Robert S Miletich, Philip D Kohn, Giuseppe Esposito, Richard E Carson, Mario Quarantelli, Daniel R Weinberger, Karen Faith Berman. Nat Neurosci 2002
449
26

Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.
Yoshitaka Kumakura, Paul Cumming, Ingo Vernaleken, Hans-Georg Buchholz, Thomas Siessmeier, Andreas Heinz, Thorsten Kienast, Peter Bartenstein, Gerhard Gründer. J Neurosci 2007
97
24

Working memory capacity predicts dopamine synthesis capacity in the human striatum.
Roshan Cools, Sasha E Gibbs, Asako Miyakawa, William Jagust, Mark D'Esposito. J Neurosci 2008
178
24

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
Stephen McGowan, Andrew D Lawrence, Tim Sales, Digby Quested, Paul Grasby. Arch Gen Psychiatry 2004
149
20

Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
Ingo Vernaleken, Yoshitaka Kumakura, Paul Cumming, Hans-Georg Buchholz, Thomas Siessmeier, Peter Stoeter, Matthias J Müller, Peter Bartenstein, Gerhard Gründer. Neuroimage 2006
54
18

Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects.
Ingo Vernaleken, Yoshitaka Kumakura, Hans-Georg Buchholz, Thomas Siessmeier, Ralf-Dieter Hilgers, Peter Bartenstein, Paul Cumming, Gerhard Gründer. Neuroimage 2008
23
39

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo.
Gerhard Gründer, Ingo Vernaleken, Matthias J Müller, Eugen Davids, Nilufar Heydari, Hans-Georg Buchholz, Peter Bartenstein, Ole L Munk, Peter Stoeter, Dean F Wong,[...]. Neuropsychopharmacology 2003
70
16


Prefrontal dopamine D1 receptors and working memory in schizophrenia.
Anissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, Roberto Gil, Diana Martinez, Yiyun Huang, Dah-Ren Hwang, John Keilp, Lisa Kochan, Ronald Van Heertum,[...]. J Neurosci 2002
498
16

Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Isabel Valli, Paul Tabraham, Elvira Bramon-Bosch, Lucia Valmaggia, Louise Johns, Matthew Broome,[...]. Arch Gen Psychiatry 2009
476
16

Relationship of striatal dopamine synthesis capacity to age and cognition.
Meredith N Braskie, Claire E Wilcox, Susan M Landau, James P O'Neil, Suzanne L Baker, Cindee M Madison, Jennifer T Kluth, William J Jagust. J Neurosci 2008
63
16

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
P Cumming, G C Léger, H Kuwabara, A Gjedde. J Cereb Blood Flow Metab 1993
69
14

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, E Eronen,[...]. Schizophr Res 1999
176
14

Striatal dopamine and working memory.
Susan M Landau, Rayhan Lal, James P O'Neil, Suzanne Baker, William J Jagust. Cereb Cortex 2009
184
14


Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, O Kirvelä, U Ruotsalainen. Lancet 1995
244
12

Elevated dopa decarboxylase activity in living brain of patients with psychosis.
J Reith, C Benkelfat, A Sherwin, Y Yasuhara, H Kuwabara, F Andermann, S Bachneff, P Cumming, M Diksic, S E Dyve,[...]. Proc Natl Acad Sci U S A 1994
239
12

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
A Abi-Dargham, R Gil, J Krystal, R M Baldwin, J P Seibyl, M Bowers, C H van Dyck, D S Charney, R B Innis, M Laruelle. Am J Psychiatry 1998
560
12


Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.
Shoko Nozaki, Motoichiro Kato, Harumasa Takano, Hiroshi Ito, Hidehiko Takahashi, Ryosuke Arakawa, Masaki Okumura, Yota Fujimura, Ryohei Matsumoto, Miho Ota,[...]. Schizophr Res 2009
49
12

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
L H Lindström, O Gefvert, G Hagberg, T Lundberg, M Bergström, P Hartvig, B Långström. Biol Psychiatry 1999
196
12


Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task.
Atsuko Nagano-Saito, Marco Leyton, Oury Monchi, Yael K Goldberg, Yong He, Alain Dagher. J Neurosci 2008
152
12

The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Oliver D Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur. Arch Gen Psychiatry 2012
522
12

Dopa decarboxylase activity of the living human brain.
A Gjedde, J Reith, S Dyve, G Léger, M Guttman, M Diksic, A Evans, H Kuwabara. Proc Natl Acad Sci U S A 1991
137
10

Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals.
N D Volkow, R C Gur, G J Wang, J S Fowler, P J Moberg, Y S Ding, R Hitzemann, G Smith, J Logan. Am J Psychiatry 1998
575
10

PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Yoshitaka Kumakura, Ingo Vernaleken, Gerhard Gründer, Peter Bartenstein, Albert Gjedde, Paul Cumming. J Cereb Blood Flow Metab 2005
40
12

Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Yoshitaka Kumakura, Albert Gjedde, Erik H Danielsen, Søren Christensen, Paul Cumming. J Cereb Blood Flow Metab 2006
33
15

Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
Anna Brück, Sargo Aalto, Elina Nurmi, Jörgen Bergman, Juha O Rinne. Neurobiol Aging 2005
93
10

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Y Okubo, T Suhara, K Suzuki, K Kobayashi, O Inoue, O Terasaki, Y Someya, T Sassa, Y Sudo, E Matsushima,[...]. Nature 1997
515
10

D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
Monte S Buchsbaum, Bradley T Christian, Douglas S Lehrer, Tanjore K Narayanan, Bingzhi Shi, Joseph Mantil, Eileen Kemether, Terrence R Oakes, Jogeshwar Mukherjee. Schizophr Res 2006
97
10



Age-related cognitive deficits mediated by changes in the striatal dopamine system.
L Bäckman, N Ginovart, R A Dixon, T B Wahlin, A Wahlin, C Halldin, L Farde. Am J Psychiatry 2000
301
10

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
A M Elkashef, D Doudet, T Bryant, R M Cohen, S H Li, R J Wyatt. Psychiatry Res 2000
74
10

A reversible tracer analysis approach to the study of effective dopamine turnover.
V Sossi, D J Doudet, J E Holden. J Cereb Blood Flow Metab 2001
52
10

Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.
Christoph Kellendonk, Eleanor H Simpson, H Jonathan Polan, Gaël Malleret, Svetlana Vronskaya, Vanessa Winiger, Holly Moore, Eric R Kandel. Neuron 2006
370
10


Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.
Dara G Ghahremani, Buyean Lee, Chelsea L Robertson, Golnaz Tabibnia, Andrew T Morgan, Natalie De Shetler, Amira K Brown, John R Monterosso, Adam R Aron, Mark A Mandelkern,[...]. J Neurosci 2012
156
10

Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making.
Lorenz Deserno, Quentin J M Huys, Rebecca Boehme, Ralph Buchert, Hans-Jochen Heinze, Anthony A Grace, Raymond J Dolan, Andreas Heinz, Florian Schlagenhauf. Proc Natl Acad Sci U S A 2015
106
10

Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype.
Andreas Meyer-Lindenberg, Philip D Kohn, Bhaskar Kolachana, Shane Kippenhan, Aideen McInerney-Leo, Robert Nussbaum, Daniel R Weinberger, Karen Faith Berman. Nat Neurosci 2005
316
8

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
S C Huang, D C Yu, J R Barrio, S Grafton, W P Melega, J M Hoffman, N Satyamurthy, J C Mazziotta, M E Phelps. J Cereb Blood Flow Metab 1991
131
8

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
A Abi-Dargham, J Rodenhiser, D Printz, Y Zea-Ponce, R Gil, L S Kegeles, R Weiss, T B Cooper, J J Mann, R L Van Heertum,[...]. Proc Natl Acad Sci U S A 2000
664
8

Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
Mirjam Talvik, Anna-Lena Nordström, Hans Olsson, Christer Halldin, Lars Farde. Int J Neuropsychopharmacol 2003
90
8

Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia.
Tetsuya Suhara, Yoshiro Okubo, Fumihiko Yasuno, Yasuhiko Sudo, Makoto Inoue, Tetsuya Ichimiya, Yoshifumi Nakashima, Kazuhiko Nakayama, Shuji Tanada, Kazutoshi Suzuki,[...]. Arch Gen Psychiatry 2002
133
8

Presynaptic dopaminergic function in the striatum of schizophrenic patients.
M H Dao-Castellana, M L Paillère-Martinot, P Hantraye, D Attar-Lévy, P Rémy, C Crouzel, E Artiges, A Féline, A Syrota, J L Martinot. Schizophr Res 1997
117
8

Prefrontal dysfunction in first-degree relatives of schizophrenia patients during a Stroop task.
Theresa M Becker, John G Kerns, Angus W Macdonald, Cameron S Carter. Neuropsychopharmacology 2008
43
9

Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.
Andreas Meyer-Lindenberg, Richard E Straub, Barbara K Lipska, Beth A Verchinski, Terry Goldberg, Joseph H Callicott, Michael F Egan, Stephen S Huffaker, Venkata S Mattay, Bhaskar Kolachana,[...]. J Clin Invest 2007
157
8

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
A Breier, T P Su, R Saunders, R E Carson, B S Kolachana, A de Bartolomeis, D R Weinberger, N Weisenfeld, A K Malhotra, W C Eckelman,[...]. Proc Natl Acad Sci U S A 1997
869
8

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
H Hoshi, H Kuwabara, G Léger, P Cumming, M Guttman, A Gjedde. J Cereb Blood Flow Metab 1993
98
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.